WO1988003365A1 - Nouveaux agents d'amelioration pour aliments a base de farine et autres aliments cuits au four et montes a la levure - Google Patents
Nouveaux agents d'amelioration pour aliments a base de farine et autres aliments cuits au four et montes a la levure Download PDFInfo
- Publication number
- WO1988003365A1 WO1988003365A1 PCT/AU1987/000371 AU8700371W WO8803365A1 WO 1988003365 A1 WO1988003365 A1 WO 1988003365A1 AU 8700371 W AU8700371 W AU 8700371W WO 8803365 A1 WO8803365 A1 WO 8803365A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- passing
- electron
- natural
- compounds
- baked goods
- Prior art date
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 60
- 235000015173 baked goods and baking mixes Nutrition 0.000 title claims abstract description 38
- 235000013312 flour Nutrition 0.000 title description 24
- 150000001875 compounds Chemical class 0.000 claims abstract description 36
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 34
- 238000000855 fermentation Methods 0.000 claims abstract description 33
- 230000004151 fermentation Effects 0.000 claims abstract description 33
- 239000000126 substance Substances 0.000 claims abstract description 26
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 claims abstract description 19
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000011768 flavin mononucleotide Substances 0.000 claims abstract description 19
- 229940013640 flavin mononucleotide Drugs 0.000 claims abstract description 19
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 claims abstract description 19
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 17
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 17
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 17
- 235000013305 food Nutrition 0.000 claims abstract description 14
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 13
- HFKPAXQHQKDLSU-MCDZGGTQSA-N (2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;pyridine-3-carboxamide Chemical compound NC(=O)C1=CC=CN=C1.C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O HFKPAXQHQKDLSU-MCDZGGTQSA-N 0.000 claims abstract description 8
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 7
- 230000023266 generation of precursor metabolites and energy Effects 0.000 claims abstract description 7
- 102000018832 Cytochromes Human genes 0.000 claims abstract description 6
- 108010052832 Cytochromes Proteins 0.000 claims abstract description 6
- XWNSFEAWWGGSKJ-UHFFFAOYSA-N 4-acetyl-4-methylheptanedinitrile Chemical compound N#CCCC(C)(C(=O)C)CCC#N XWNSFEAWWGGSKJ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000004153 Potassium bromate Substances 0.000 claims abstract description 5
- 235000019396 potassium bromate Nutrition 0.000 claims abstract description 5
- 229940094037 potassium bromate Drugs 0.000 claims abstract description 5
- 230000035806 respiratory chain Effects 0.000 claims abstract description 5
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 4
- 102000015439 Phospholipases Human genes 0.000 claims abstract description 4
- 108010064785 Phospholipases Proteins 0.000 claims abstract description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 4
- 239000010452 phosphate Substances 0.000 claims abstract description 4
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 claims abstract description 4
- 229940080352 sodium stearoyl lactylate Drugs 0.000 claims abstract description 4
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract 2
- 150000003669 ubiquinones Chemical class 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 29
- 239000000284 extract Substances 0.000 claims description 22
- 230000008569 process Effects 0.000 claims description 19
- 239000004129 EU approved improving agent Substances 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 239000004382 Amylase Substances 0.000 claims description 13
- 230000009467 reduction Effects 0.000 claims description 12
- 229920002472 Starch Polymers 0.000 claims description 10
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 10
- 235000019698 starch Nutrition 0.000 claims description 10
- 239000008107 starch Substances 0.000 claims description 10
- 230000018044 dehydration Effects 0.000 claims description 8
- 238000006297 dehydration reaction Methods 0.000 claims description 8
- 238000011084 recovery Methods 0.000 claims description 7
- 238000005352 clarification Methods 0.000 claims description 6
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 5
- 229960005305 adenosine Drugs 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 102000011420 Phospholipase D Human genes 0.000 claims description 3
- 108090000553 Phospholipase D Proteins 0.000 claims description 3
- 235000013405 beer Nutrition 0.000 claims description 3
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 claims description 2
- 239000005862 Whey Substances 0.000 claims description 2
- 102000007544 Whey Proteins Human genes 0.000 claims description 2
- 108010046377 Whey Proteins Proteins 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000027756 respiratory electron transport chain Effects 0.000 claims description 2
- 230000006641 stabilisation Effects 0.000 claims description 2
- 235000016046 other dairy product Nutrition 0.000 claims 1
- 239000003638 chemical reducing agent Substances 0.000 abstract description 15
- 102000004190 Enzymes Human genes 0.000 abstract description 12
- 108090000790 Enzymes Proteins 0.000 abstract description 12
- 239000005515 coenzyme Substances 0.000 abstract description 7
- 239000002699 waste material Substances 0.000 abstract description 7
- 244000005700 microbiome Species 0.000 abstract description 6
- -1 e.g. Proteins 0.000 abstract description 5
- 239000000654 additive Substances 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 abstract description 3
- 229940001584 sodium metabisulfite Drugs 0.000 abstract description 3
- 235000010262 sodium metabisulphite Nutrition 0.000 abstract description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract description 2
- 235000019192 riboflavin Nutrition 0.000 abstract description 2
- 229960002477 riboflavin Drugs 0.000 abstract description 2
- 239000002151 riboflavin Substances 0.000 abstract description 2
- 239000004156 Azodicarbonamide Substances 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 abstract 1
- 150000003838 adenosines Chemical class 0.000 abstract 1
- XOZUGNYVDXMRKW-AATRIKPKSA-N azodicarbonamide Chemical compound NC(=O)\N=N\C(N)=O XOZUGNYVDXMRKW-AATRIKPKSA-N 0.000 abstract 1
- 235000019399 azodicarbonamide Nutrition 0.000 abstract 1
- 230000037149 energy metabolism Effects 0.000 abstract 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 52
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 45
- 239000000047 product Substances 0.000 description 38
- 235000008429 bread Nutrition 0.000 description 26
- 230000000694 effects Effects 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 239000002207 metabolite Substances 0.000 description 13
- 108010068370 Glutens Proteins 0.000 description 12
- 235000021312 gluten Nutrition 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 8
- 230000000813 microbial effect Effects 0.000 description 7
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 7
- 108010063907 Glutathione Reductase Proteins 0.000 description 6
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 6
- 239000007795 chemical reaction product Substances 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 230000027721 electron transport chain Effects 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000003801 milling Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- 108020005199 Dehydrogenases Proteins 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 241000589220 Acetobacter Species 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000575946 Ione Species 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- LTXREWYXXSTFRX-QGZVFWFLSA-N Linagliptin Chemical compound N=1C=2N(C)C(=O)N(CC=3N=C4C=CC=CC4=C(C)N=3)C(=O)C=2N(CC#CC)C=1N1CCC[C@@H](N)C1 LTXREWYXXSTFRX-QGZVFWFLSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical group NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 101001061492 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Partitioning protein REP1 Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000007824 aliphatic compounds Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 238000000498 ball milling Methods 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 230000002478 diastatic effect Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000011552 falling film Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000005480 nicotinamides Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019449 other food additives Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 239000004458 spent grain Substances 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
- A21D2/26—Proteins
- A21D2/267—Microbial proteins
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/30—Organic phosphorus compounds
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
- A21D2/368—Fermentation by-products, e.g. grapes, hops
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D8/00—Methods for preparing or baking dough
- A21D8/02—Methods for preparing dough; Treating dough prior to baking
- A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
- A21D8/042—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
Definitions
- the present invention relates to the use o highly purified natural improving agents in the productio of bread and other yeast raised baked goods. It als relates to the recovery of extracts containing highl purified improving agents for use in bread and other yeas raised baked goods, which are derived from the residues o "waste" products of fermentation and food productio industries and to the use of these highly concentrated foo quality improving agents in the production of bread an other yeast raised baked goods. BACKGROUND ART
- the making of bread uses mechanical operations such as kneading the dough, dividing the dough into pieces, and moulding into a predetermined form before proofing and baking.
- the physical properties of the dough such as elasticity, extensibility, non-stickiness and ability to be. moulded are dependent on a combination of factors including the quality of the flour, the quality of the gluten, and/or the presence of other food additives.
- the quality of the final baked product as judged by parameters such as crumb softness, volume, texture, taste, mouthfeel etc., is equally dependent upon the above physical properties and is affected by both the chemical and is biological parameters.
- the period of bulk fermentation is important. It is a resting period, during which time the yeast ferments, interacts with the gluten in the dough, and the dough itself changes from a rough, dense mass with poor gas retention and lacking extensibility, into a smooth extensible dough with good gas retaining properties. Such properties are essential to the production of a loaf with good volume, soft yet resilient with fine crumb cell structure; Any method of bread making which omits bulk dough fermentation can only succeed in
- fermented flour and whey additives have become available, e.g., Empruv, Fermitech etc, which claim to cause an improvement in the quality of doughs to which they are added including sensory and olfactory parameters. 5
- These manifestations are obvious to those persons with ordinary skill in the art. Coupled with our observations that the greater the contact time (from 2 to 24 hours) between the yeast and dough, sponge, brew or ferment system, the better leavening, texture, flavour and 0 resistance to staling in the bread or other yeast raised baked goods, led us to postulate that a metabolite or group • of metabolites formed during the fermentation acted upon the gluten and then on the physical properties of the dough in a beneficial manner.
- These improving agents are highly purified substances, including nicotinamide adenosine dinucleotide, flavin ononucleotide, flavin adenosine dinucleotide, the cytochromes, and the ubiguinones, derived from biological systems; the improving agents also include components and 5 derivatives of these substances, e.g., nicotinamide, riboflavin etc.
- chemical improving agents such as potassium bromate, sodium metabisulfite, sodium stearoyl lactylate or the diacetyl tartaric esters of monoglycerides or distilled monoglycerides
- .UBST1TUTE ⁇ ⁇ l ⁇ _ fermentation residues e.g., from breweries, wineries, starch plants and dairies of highly concentrated natura novel improving agents for yeast raised baked goods.
- the present invention provides food quality novel natural improving agents for yeast raised baked goods, including any one of, or any combination of, natural electron transfer biological oxido-reductants including oxidative chain phosphorylation components or derivatives thereof, including for example:- NAD nicotinamide adenosine dinucleotide NADP nicotinamide adenosine dinucleotide phosphate
- FMN flavin mononucleotide FAD flavin adenosine dinucleotide Ubiguinones - i.e., the coenzymes 0 Cytochromes and other components of the electron transport chain.
- the present invention relates to the use of such oxido-reductants or electron passing compounds, either singularly or in any combination as food quality improving agents, especially in the production of yeast raised baked goods as a full or partial replacement of, or in addition to, chemical improving agents.
- SUBSTITUTE SH ET These compounds may be used either in a highly purified state or as components of concentrates and extracts contained in or derived from spent residues from the fermentations of yeasts (especially of the Saccharomyces genus) as for example from beer, wine and other alcoholic beverages, and also from the spent residues from fermentations of other micro-organisms, e.g., Acetobacter, Lactobacillus, Aspergillus, Leuconostoc and Streptococcus species. Also, starch plant residues and dairy residues. Generally, the concentrations of the electron-passing compounds employed are at least 0.001% by weight, normally expressed as a percentage of the weight of flour in the mixture.
- NAD and NADP are natural oxido-reductant present in most biochemical systems. They are coenzymes for a wide variety of enzymes. The NAD dependent enzymes exhibit several modes of action, four of which are discussed herein.
- the NAD dependent dehydrogenases catalyse the oxidation of alcohols, aldehydes, c- and /B-hydroxy carboxylic acids and c-amino acids.
- the nucleotides themselves readily accept electrons from a reduced substrate or donate electrons to an oxidised substrate in a coupled reaction such as
- the nicotinamide nucleotides function in reduction o f the flavin coenzymes . These provide the link in the e le c tron transport chain between NAD an FMN or FAD .
- An example is the reduction u * oxidised glutathione by glutathione reductase .
- Glutathione reductases are enzymes which contain FAD as a prosthetic group.
- the FAD reacts with the NADH as shown
- the nicotinamide nucleotides provide a source of electrons for the hydroxylation and desaturation of both aromatic and aliphatic compounds as for example in lipid metabolism.
- a further function of NAD is in the repair mechanism of DNA, catalysed by DNA- ⁇ gase.
- NAD is an end product of alcoholic fermentation. It is also one of the end products of intermediary metabolism. Historically, its function in yeast raised baked goods depends upon an interaction with the glutathione reductase system and the oxidation of reduced glutathione. While glutathione reductase has been reported to have specificity for NADP, NAD can collect H atoms from substrates acted upon NADP linked dehydrogenases.
- the thiol/disulfide interchange represents a dynamically changing system dependent on the number, and distribution of these functional groups, i.e., either intermolecular or intramolecular, as well as the
- Yeast is a living organism. As such it requires nutrients during its logarithmic growth phase. T hese are provi d ed from the constituents of the flour an d /or by the ad d ition of yeast foods e.g., sugar, nitrogen sources and trace elements. Secondly, yeast cell membrane constituents ' come into direct contact with the gluten in the dough. The possibility exists for interactions between the constituents o ' f the yeast membrane and those of the gluten. T hir d ly, living cells have a finite life span. m longer fermentation doughs the percentage of damaged or d ea d yeast cells will ⁇ be higher than in . short time d oughs. Consequently there will be released into the fermenting d ough, intracellular enzymes, coenzymes and other metabolites.
- a ccording to the present invention it can be shown that the spent yeast and micro-organisms of fermentations are a rich source of such metabolites.
- Fresh Baker's yeast is the usual source of commercial NAD and related metabolites, although patents describing its
- SUBSTITUTE SHEET production and purification from aerobic culturing of micro-organisms are extant (e.g., see USP 3,705,080; USP 3,705,081; USP 3,708,394 and USP 3,709,786) .
- NAD is produced as an end product of ethanolic and lactic fermentations: acetaidehyde + NADH a ?° ⁇ ⁇ ethanol + NAD +
- NAD pyruvic acid + NADH lactic acid + NAD + it has now been surprisingly discovered according to the invention that its concentration in the end products of alcoholic and lactic fermentations and in the microbial residues from such fermentations is an order of magnitude greater than in baker's yeast, thus making its recovery commercially viable.
- NAD is estimated using the enzyme catalysed oxidation of ethanol to acetaidehyde at pH 9.0.
- the reaction mixture consists of lOOmM phosphate buffer pH 9.0, ethanol 170mM, alcohol dehydrogenase (Boehringer Mannheim)
- .UBSTTTUTE SH ⁇ e.g., or;-amylase, ascorbic acid etc., in breads and yeast raised baked goods had not previously been described or understood.
- NAD and the related compounds according to the present invention act as strong oxidising agents on gluten, either alone or when in combination with flour, but at the same time increase extensibility of the dough.
- the oxidising power of the NAD and related compounds is reduced without a concomitant o significant reduction in extensibility of the dough.
- the presence of ascorbic acid and c ⁇ -amylase may be beneficial to produce maximum advantage with respect to volume? texture; mouthfeel and other physical parameters.
- some embodiments of the improving agent may also comprise one or more additives selected from of-amylase , ascorbic acid and phospholipase A and/or phospholipase D, in an appropriate effective amount, usually at levels of not less than 0.0001% by weight. 0 Sources of NAD and Related Compounds.
- natural sources of NAD, FAD, FMN, NADP, the ubiguinones are the end products of microbial fermentations.
- examples of possible sources include:- (i) yeast residues from breweries 5 (ii) spent grain from breweries
- yeast residues relate to extensive tests and processing of yeast residues from breweries but also include those from wine lees.
- the yeast residue is a thick cake, still biologically active but with a high moisture and - ethanol content.
- the yeast cells contain large intracellular concentrations of NAD, in addition to other components of the electron transport chain and intermediar metabolism as previously cited.
- the preferred method for the processing of the residues from fermentation systems in order to obtain highl purified extracts and residues for use in yeast raised baked goods may comprise some of or all of the following processes in any combination or order:-
- High pressure homogenisation and freezing (or heating) of the fermented residue and residue products of fermentation are two of the methods which have been employed according to the invention to disrupt and/or weaken the cell walls of the yeast.
- Other methods may include for example, extrusion, colloid milling, microwaving, lysozymes, solvent extraction, high pressure spray drying, vibration ball milling, treatment with ultrasonics and grinding.
- Cell disruption may be followed by inactivation of deleterious enzyme and other catalytic systems by appropriate physical and chemical change.
- a number of techniques may be employed to inactivate enzyme systems, including elevating or depressing temperatures, adjustment of pH or combinations of these.
- the fermented microbial residues or the cell disrupted microbial residues are diluted with water to a viscosity approaching that of water.
- the diluted mixture is subjected to a temperature greater than 45°C but substantially less that 200°C for a period of not more that 30 minutes. This is of extreme importance not only as a consequence of inactivating deleterious enzyme systems, but also because of the final yield and quality of the NAD and the other oxido-reductants and metabolites hitherto described.
- Clarification of the cell disrupted enzyme inactivated fermented waste to remove cell debris from the extract containing the NAD and other metabolites is successfully achieved by centrifugation of filtration, e.g., the use of Sharpies decanter or starch bed filtration.
- filter aids such as diatomaceous earth, vacuum drum filtration flocculation, flotation bubbles, pressure candles, enzymes or membranes.
- the present invention relates to a process for producing a highly concentrated extract from one of a group of fermented residues and "waste" residues of fermentations including brewery residues, winery residues, lactic fermentation residues containing the natural oxido-reductant NAD and related compounds previously described. It will be understood by those skilled in the art that several dehydration and concen t ration techniques may be applied to obtain the highly concentrated dehydrated extract include
- a highly concentrated liquid extract may be obtained by any or all of a variety of concentration processes including utrafiltration, reverse osmosis, falling film evaporators, and the like.
- Each of these methods of dehydration and concentration can be used on the crude ferment residues or on the extract containing the active principles of the coenzymes, metabolites and oxido-reductants. Freeze drying of the heat treated residue, the heat treated extract and the residual cell debris, have provided free-flowing products. Dehydration of both the heat-treated residue and extract provided products which, when baked, results in significant improvement in volume, crumb texture and ⁇ retardation of staling in yeast raised baked goods. Addition of the crude residue or the heat treated extract to starch in a 1:1 ratio permitted the dehydration to be carried out using a fludised bed drier. The final product required grinding but provides increases in NAD and in volume and improved textural characteristics in bread and yeast raised baked goods.
- the products herein described can be successfully obtained by spray drying.
- the preferred method uses an inlet temperature into the spray drier of between about 180°C and 300°C and an outlet temperature of between 70°C and 120°C. Advantages of lower inlet and outlet temperatures on the performance of the final spray dried concentrate in yeast raised baked goods will be obvious to those skilled in the art in view of the present disclosure.
- the present invention relates to the novel use of naturally occurring oxido-reductants, metabolites and coenzymes in bread and other yeast raised baked goods as in adjunct to currently available "chemical improvers", or as a
- Yeast is Mauripan Active Dried Yeast produced by Mauri
- SUBSTITUTE SHEET Representative volumes for 3 loaves baked on th same day are given. values which differ from controls b more than 100 units are significant. * Significant at the p ⁇ 0.05 level. The lower th value the softer the bread.
- Example 3 Crumb structure and texture in loaves containing the product of Example 1 were markedly different from those containing only V8 or natural improver.
- the crumb structure is much finer, cells are small and elliptical in shape.
- the crumb is more resilient and possesses an iridescent sheen.
- Example 3
- Example 4 As can be seen from the above representative sample, the addition of pure NAD provided an increase in volume as well as a retardation in the onset of staling. Crumb structure and texture replicated that seen in the loaves baked using the highly concentrated extract of Example 1. Example 4.
- loaves of bread were made by mixing the raw materials as set out in Table 1 and using the same breadmaking process of Example 2 , using varying levels of: a) the extract obtained from the process of Example 1 and ascorbic acid, b) Pure NAD and ascorbic acid. Representative results for wholemeal are shown in Table 4.
- Loaf volumes guoted are representative only and vary from day to day. Results in Table 4 show the NAD and the product from Example 1 interact with ascorbic acid in the dough. Unless ascorbic acid is present the NAD and product from Example 1 exert such a strong effect on the dough, that there is a resultant reduction in loaf volume.
- the following example illustrates the effects of flavin adenosine dinucleotide (FAD) as an improving agent with similar properties to those of NAD and the highly concentrated extract of Example 1.
- FAD flavin adenosine dinucleotide
- Example 2 The following example illustrates the effects of flavin adenosine dinucleotide (FAD) as an improving agent with similar properties to those of NAD and the highly concentrated extract of Example 1.
- FAD flavin adenosine dinucleotide
- Example 7 The following example illustrates the effects of flavin mononucleotide (FMN) as an improving agent with similar properties to those of NAD and the highly concentrated extract of Example 1.
- FMN flavin mononucleotide
- Table 6 The results from these tests show in Table 6 that the 0.005% level of addition of FMN is preferred.
- Crumb structure and texture was similar to that of loaves baked using the products from Example 1 and Example 3.
- Table 6 Effect of FMN addition on Loaf volume. Loaf volume
- Example 10 This example pertains to the use of the product from Example 9 as an improving agent in yeast raised baked goods. Loaves of bread were formulated using the raw ingredients of Table 1 and baked according to the description of Example 2. volumes of the loaves were measured by rapeseed displacement and recorded. Crumb structure and texture were noted.
- Example 9 which is a highly concentrated extract from wine lees provides an increase in loaf volume and crumb structure and texture similar to that obtained with pure NAD, FAD, FMN or the product of Example 1.
- Example 11 The following example illustrates the effect of the addition of product from Example 1 to proprietary chemical improvers containing emulsifiers.
- White and wholemeal loaves were baked as hitherto described using s.uch improvers.
- Representative values for vol m e and staling measurements for both white and wholemeal are shown in Table 9 .
- the results ind icate that the presence of the product o Ex amp le 1 and emu ls i f ie rs in a chem i ca l improve r g i ve s ignif icant increase in volume .
- NAF and TN80 are proprietary improvers produced by Cereform, Wetherill Park, New South Wales, Australia, containing potassium bromate, sodium metabisulfite, ascorbic acid, L-cysteine and emulsifiers such as sodium stearoyl lactylate.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Groupe de nouveaux agents d'amélioration naturels qui sont destinés à des aliments cuits au four et montés à la levure et qui comprennent des produits dérivés des résidus des processus de fermentation éthyliques et autres de micro-organismes (par exemple lactiques). Les composants actifs extraits de ces résidus constituent les composés à transfert d'électrons naturels de la chaîne respiratoire et du métabolisme intermédiaire tel qu'il est lié au métabolisme énergétique. Lesdits composés comprennent un dinucléotide d'adénosine de nicotinamide, et son phosphate, un mononucléotide de flavine à base d'un nucléotide d'adénosine de flavine, les ubiquinones, des cytochromes, etc., et les composants de ces substances, tels que de la nicotinamide, de la riboflavine, etc., ainsi que leurs dérivés. Des améliorations significatives sont apportées à la qualité finale des aliments cuits au four et montés à la levure par ces agents d'oxydo-réduction naturels et par les co-enzymes, et notamment à la qualité finale des aliments de ce type qui ne contiennent pas d'émulsifiants ou d'agents d'oxydo-réduction traditionnels ou ''chimiques''. Par agents d'oxydo-réduction ''chimiques'', on se réfère aux substances chimiques telles que le bromate de potassium, le métabisulfite de sodium, l'azodicarbonamide, etc., qui ne sont pas biologiques. Par agents d'oxydo-réduction ''biologiques'' ou ''naturels'', on se réfère à des substances qui sont naturellement présentes dans la nourriture et dans d'autres produits biologiques, sans tenir compte du fait qu'elles peuvent être synthétisées chimiquement, comme c'est le cas de l'acide ascorbique, et de l'hydrochlorure de L-cystéine. Les agents d'oxydo-réduction ''naturels'' signifient en outre que lesdites substances peuvent être extraites de substances biologiques naturellement présentes, telles que des résidus. L'addition desdits agents d'amélioration naturels dans des aliments cuits au four et montés à la levure permet d'éliminer le besoin d'utilisation d'additifs chimiques dans ces produits et également de remplacer partiellement ou totalement dans le mélange les émulsifiants, tels que le lactylate de stéaroyle de sodium, et les enzymes, telles que les protéases, les phospholipases, etc., qui sont communément employés lorsque des agents d'oxydo-réduction chimiques sont utilisés.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPH881386 | 1986-11-05 | ||
| AUPH8813 | 1986-11-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1988003365A1 true WO1988003365A1 (fr) | 1988-05-19 |
Family
ID=3771877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/AU1987/000371 WO1988003365A1 (fr) | 1986-11-05 | 1987-11-05 | Nouveaux agents d'amelioration pour aliments a base de farine et autres aliments cuits au four et montes a la levure |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP0438386A4 (fr) |
| WO (1) | WO1988003365A1 (fr) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991012724A1 (fr) * | 1990-03-02 | 1991-09-05 | Takeda Chemical Industries, Ltd. | Pains et leur production |
| WO1999057986A1 (fr) * | 1998-05-13 | 1999-11-18 | Novo Nordisk Biotech, Inc. | Procede d'utilisation de deshydrogenases en boulangerie |
| WO2002060263A3 (fr) * | 2001-01-31 | 2002-10-24 | Dsm Nv | Vinasse en boulangerie |
| EP1123656A3 (fr) * | 2000-02-10 | 2003-07-30 | Snow Brand Milk Products, Co., Ltd. | Produits de boulangerie contenant de l'azote non protéique |
| EP1358807A3 (fr) * | 2002-05-03 | 2004-03-17 | Agro-korn a/s | Utilisation de la vinasse de production d' éthanol comme ingredient fonctionnel pour produits alimentaires |
| EP1474992A4 (fr) * | 2002-01-18 | 2005-04-13 | Kaneka Corp | Aliments enrichis en ubiquinone |
| FR2906969A1 (fr) * | 2006-09-25 | 2008-04-18 | Jacques Olivier Gratiot | Procede de fabrication d'un produit alimentaire, notamment boulanger |
| FR2906970A1 (fr) * | 2006-09-25 | 2008-04-18 | Jacques Olivier Gratiot | Procede de fabrication d'un produit alimentaire boulanger |
| US7371423B2 (en) | 1997-04-09 | 2008-05-13 | Danisco, A/S | Method for preparing flour doughs and products made from such doughs using lipase |
| US7622290B2 (en) | 2004-03-12 | 2009-11-24 | Danisco A/S | Fungal lipolytic enzymes, nucleic acids encoding, and uses thereof |
| US7638293B2 (en) | 2003-01-17 | 2009-12-29 | Danisco A/S | Method |
| USRE43135E1 (en) | 2001-05-18 | 2012-01-24 | Danisco A/S | Method of improving dough and bread quality |
| USRE43341E1 (en) | 1995-06-07 | 2012-05-01 | Danisco A/S | Method of improving the properties of a flour dough, a flour dough improving composition and improved food products |
| US8889371B2 (en) | 2004-07-16 | 2014-11-18 | Dupont Nutrition Biosciences Aps | Lipolytic enzyme: uses thereof in the food industry |
| GR1010257B (el) * | 2021-02-10 | 2022-06-27 | K.M.P.M Agrovision Διαφημιστικη-Εκτυπωτικη Ιδιωτικη Κεφαλαιουχικη Εταιρεια, | Μεθοδος παρασκευης ζυμης και προϊοντων ζυμης με τη χρηση οινολασπης |
Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB578626A (en) * | 1943-06-05 | 1946-07-05 | Albert Green | Improvements in or relating to methods for the manufacture of special bakers' flours |
| US3466176A (en) * | 1967-12-20 | 1969-09-09 | Beatrice Foods Co | Manufacture of synthetic bread flavor |
| US3681083A (en) * | 1970-02-27 | 1972-08-01 | Merck & Co Inc | Method of making sour dough bread |
| US3689641A (en) * | 1970-08-20 | 1972-09-05 | Merck & Co Inc | Concentrated water suspension of nutrients |
| US3830938A (en) * | 1971-04-14 | 1974-08-20 | Sankyo Co | Method of making bread of high sugar content |
| AU7844475A (en) * | 1974-03-05 | 1976-08-26 | Societe Des Produits Nestle S.A. | A process FOR SUPPLEMENTING FOODSTUFFS LOWIN LYSINE |
| US4093748A (en) * | 1975-12-27 | 1978-06-06 | Eisai Co., Ltd. | Process for the preparation of bread |
| AU3065777A (en) * | 1976-12-15 | 1979-05-24 | Stauffer Chemical Company | Whey protein enriched baked goods |
| US4243687A (en) * | 1979-01-10 | 1981-01-06 | Leo Kline | Freeze-dried natural sour dough starter |
| EP0097251A1 (fr) * | 1982-05-29 | 1984-01-04 | Korn, Helmut, Ing.-grad. | Produits de boulangerie et pâtes alimentaires à partir de farine granuleuse à pulvérulente de céréales et de produits d'addition |
| AU1627283A (en) * | 1982-06-30 | 1984-01-05 | Nisshin Flour Milling Inc. | Producing barm for bakery and pastry products |
| AU4592985A (en) * | 1984-08-10 | 1986-02-13 | Kyowa Hakko Kogyo Co. Ltd. | Flour improving agent |
| GB2167283A (en) * | 1984-10-23 | 1986-05-29 | Matti Siren | Food composition containing inositol triphosphate |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR714969A (fr) * | 1930-05-10 | 1931-11-23 | Procédé de panification | |
| DE2208301A1 (de) * | 1972-02-22 | 1973-09-06 | Berdelle Hilge Philipp | Proteinangereicherte backwaren und verfahren zu deren herstellung |
| JPS5851853A (ja) * | 1981-09-18 | 1983-03-26 | Kyowa Hakko Kogyo Co Ltd | リン脂質混合物の処理法 |
-
1987
- 1987-11-05 WO PCT/AU1987/000371 patent/WO1988003365A1/fr not_active Application Discontinuation
- 1987-11-05 EP EP19870907496 patent/EP0438386A4/en not_active Withdrawn
Patent Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB578626A (en) * | 1943-06-05 | 1946-07-05 | Albert Green | Improvements in or relating to methods for the manufacture of special bakers' flours |
| US3466176A (en) * | 1967-12-20 | 1969-09-09 | Beatrice Foods Co | Manufacture of synthetic bread flavor |
| US3681083A (en) * | 1970-02-27 | 1972-08-01 | Merck & Co Inc | Method of making sour dough bread |
| US3689641A (en) * | 1970-08-20 | 1972-09-05 | Merck & Co Inc | Concentrated water suspension of nutrients |
| US3830938A (en) * | 1971-04-14 | 1974-08-20 | Sankyo Co | Method of making bread of high sugar content |
| AU7844475A (en) * | 1974-03-05 | 1976-08-26 | Societe Des Produits Nestle S.A. | A process FOR SUPPLEMENTING FOODSTUFFS LOWIN LYSINE |
| US4093748A (en) * | 1975-12-27 | 1978-06-06 | Eisai Co., Ltd. | Process for the preparation of bread |
| AU3065777A (en) * | 1976-12-15 | 1979-05-24 | Stauffer Chemical Company | Whey protein enriched baked goods |
| US4243687A (en) * | 1979-01-10 | 1981-01-06 | Leo Kline | Freeze-dried natural sour dough starter |
| EP0097251A1 (fr) * | 1982-05-29 | 1984-01-04 | Korn, Helmut, Ing.-grad. | Produits de boulangerie et pâtes alimentaires à partir de farine granuleuse à pulvérulente de céréales et de produits d'addition |
| AU1627283A (en) * | 1982-06-30 | 1984-01-05 | Nisshin Flour Milling Inc. | Producing barm for bakery and pastry products |
| AU4592985A (en) * | 1984-08-10 | 1986-02-13 | Kyowa Hakko Kogyo Co. Ltd. | Flour improving agent |
| GB2167283A (en) * | 1984-10-23 | 1986-05-29 | Matti Siren | Food composition containing inositol triphosphate |
Non-Patent Citations (6)
| Title |
|---|
| DERWENT ABSTRACT Accession No. 41273Y/23, class D11, SU,A, 528077 (KIEV FOOD IND TECH) 5 October 1976 (05.10.76). * |
| DERWENT ABSTRACT Accession No. 83-739811/33, class D11, SU,A, 965415 (KAUN POLY) 18 October 1982 (18.10.82). * |
| International Patent Classification Fourth Edition (1984) Volume 3 Section C published by WIPO. See sub-group headings C12P 7/26, 17/12, 19/36, 21/02, 25/00 at pages 180, 181, 182. * |
| Ninth edition of The Merck Index published by Merck & Co., Inc. U.S.A. (1976). See monograph Numbers 2788, 2789, 4007, 6170, 6172, 6340, 7993 and 9496 at pages 366, 532, 824, 846, 1064, 1065 and 1263. * |
| PATENTS ABSTRACTS OF JAPAN, C77, page 4362, JP,A, 52-130977 (ORIENTAL KOBO KOGYO K.K.) 11 February 1977 (11.02.77). * |
| See also references of EP0438386A4 * |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991012724A1 (fr) * | 1990-03-02 | 1991-09-05 | Takeda Chemical Industries, Ltd. | Pains et leur production |
| USRE43341E1 (en) | 1995-06-07 | 2012-05-01 | Danisco A/S | Method of improving the properties of a flour dough, a flour dough improving composition and improved food products |
| US7371423B2 (en) | 1997-04-09 | 2008-05-13 | Danisco, A/S | Method for preparing flour doughs and products made from such doughs using lipase |
| WO1999057986A1 (fr) * | 1998-05-13 | 1999-11-18 | Novo Nordisk Biotech, Inc. | Procede d'utilisation de deshydrogenases en boulangerie |
| EP1123656A3 (fr) * | 2000-02-10 | 2003-07-30 | Snow Brand Milk Products, Co., Ltd. | Produits de boulangerie contenant de l'azote non protéique |
| WO2002060263A3 (fr) * | 2001-01-31 | 2002-10-24 | Dsm Nv | Vinasse en boulangerie |
| USRE43135E1 (en) | 2001-05-18 | 2012-01-24 | Danisco A/S | Method of improving dough and bread quality |
| US7678404B2 (en) | 2002-01-18 | 2010-03-16 | Kaneka Corporation | Ubiquinone-enriched foods |
| EP1474992A4 (fr) * | 2002-01-18 | 2005-04-13 | Kaneka Corp | Aliments enrichis en ubiquinone |
| AU2003203261B2 (en) * | 2002-01-18 | 2007-11-29 | Kaneka Corporation | Ubiquinone-enriched foods |
| EP1358807A3 (fr) * | 2002-05-03 | 2004-03-17 | Agro-korn a/s | Utilisation de la vinasse de production d' éthanol comme ingredient fonctionnel pour produits alimentaires |
| US7638293B2 (en) | 2003-01-17 | 2009-12-29 | Danisco A/S | Method |
| US7622290B2 (en) | 2004-03-12 | 2009-11-24 | Danisco A/S | Fungal lipolytic enzymes, nucleic acids encoding, and uses thereof |
| US8889371B2 (en) | 2004-07-16 | 2014-11-18 | Dupont Nutrition Biosciences Aps | Lipolytic enzyme: uses thereof in the food industry |
| FR2906970A1 (fr) * | 2006-09-25 | 2008-04-18 | Jacques Olivier Gratiot | Procede de fabrication d'un produit alimentaire boulanger |
| FR2906969A1 (fr) * | 2006-09-25 | 2008-04-18 | Jacques Olivier Gratiot | Procede de fabrication d'un produit alimentaire, notamment boulanger |
| GR1010257B (el) * | 2021-02-10 | 2022-06-27 | K.M.P.M Agrovision Διαφημιστικη-Εκτυπωτικη Ιδιωτικη Κεφαλαιουχικη Εταιρεια, | Μεθοδος παρασκευης ζυμης και προϊοντων ζυμης με τη χρηση οινολασπης |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0438386A1 (fr) | 1991-07-31 |
| EP0438386A4 (en) | 1991-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2149458C (fr) | Procede de preparation de milieux pour la culture de levures et de bacteries lactiques, et utilisation de ces milieux | |
| WO1988003365A1 (fr) | Nouveaux agents d'amelioration pour aliments a base de farine et autres aliments cuits au four et montes a la levure | |
| EP0684308B2 (fr) | Procédé d'obtention d'une biomasse et ferment de panification | |
| EP0298605A1 (fr) | Procédé de production d'une composition bactèrielle stable et procédé de panification en utilisant cette composition | |
| JP2010507375A (ja) | 新規のビタミンd2酵母調製物、製造方法、および使用方法 | |
| US6465027B1 (en) | Ready-to-use long conservation baker's leaven | |
| EP0727943B1 (fr) | Procédé pour la préparation d'une pâte | |
| RU99108725A (ru) | Готовые к употреблению пекарские дрожжи длительного хранения | |
| EP1541671B1 (fr) | Nouvelle levure de boulanger et pain fait avec cette dernière | |
| EP3358959B1 (fr) | Produits levants liquides stables | |
| Jenson | Bread and baker’s yeast | |
| AU8272187A (en) | Novel improvers for flour and yeast raised baked goods | |
| HU230751B1 (hu) | Folyékony élesztőkészítmények | |
| JP3193506B2 (ja) | 飲食品の製造法 | |
| CA2149455C (fr) | Procede de preparation d'une biomasse sur un milieu de cereale, utilisation des produits ainsi prepares comme ferment de panification | |
| Oda et al. | Construction of a sucrose-fermenting bakers' yeast incapable of hydrolysing fructooligosaccharides | |
| CA2164104A1 (fr) | Methode pour ameliorer les proprietes des cereales maltees | |
| JPH0515420B2 (fr) | ||
| Poitrenaud | Baker’s yeast | |
| JP3260919B2 (ja) | 飲食品の製造法 | |
| SU1708233A1 (ru) | Способ приготовлени пшеничного теста | |
| JP5285987B2 (ja) | パン酵母 | |
| CA2153559C (fr) | Levure de pain resistant a la congelation ainsi qu'au sucre | |
| ABDEL-RAHIM et al. | Effect of some additives on leaveners and dough quality | |
| Champagne et al. | Fermentative activity of baker's yeast cultivated on cheese whey permeate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CH DK FI JP KR NO US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1987907496 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1987907496 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 1987907496 Country of ref document: EP |